I agree that this site is using cookies. You can find further informations here.
X
Terzolo, S.
97  results:
OpenAccess-fulltext X
Search for persons X
?
1

Confirmatory validation analysis of the PROFFIT questionnai..:

Arenare, L ; Porta, C ; Barberio, D...
https://research.stmarys.ac.uk/id/eprint/6162/1/PIIS2059702923014333.pdf.  , 2023
Link: https://research.stmarys..
 
?
2

Confirmatory validation analysis of the PROFFIT questionnai..:

Arenare, L ; Porta, C ; Barberio, D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774953/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

Comorbidities in mild autonomous cortisol secretion and the..:

Pelsma, I.C.M ; Fassnacht, M ; Tsagarakis, S...
https://eprints.whiterose.ac.uk/208065/1/lvad134.pdf.  , 2023
Link: https://eprints.whiteros..
 
?
4

European Society of Endocrinology clinical practice guideli..:

Fassnacht, M ; Tsagarakis, S ; Terzolo, M...
https://eprints.whiterose.ac.uk/208070/1/lvad066.pdf.  , 2023
Link: https://eprints.whiteros..
 
?
5

Phase II study of cabazitaxel as second-third line treatmen..:

Laganà, M ; Grisanti, S ; Ambrosini, R...
info:eu-repo/semantics/altIdentifier/pmid/35272132.  , 2022
Link: https://hdl.handle.net/2..
 
?
6

Age-dependent and sex-dependent disparity in mortality in p..:

Deutschbein, T ; Reimondo, G ; Di Dalmazi, G...
https://eprints.whiterose.ac.uk/187083/1/NAPACA%20Outcome%20-%20Main%20Manuscript%20-%2022-03-09%20clean%20version.pdf.  , 2022
Link: https://eprints.whiteros..
 
?
7

S-GRAS score for prognostic classification of adrenocortica..:

Elhassan Y. S ; Altieri B ; Berhane S...
info:eu-repo/semantics/altIdentifier/pmid/34709200.  , 2022
Link: http://hdl.handle.net/23..
 
?
8

Phase II study of cabazitaxel as second-third line treatmen..:

Laganà, M ; Grisanti, S ; Ambrosini, R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058897/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

Age-dependent and sex-dependent disparity in mortality in p..:

Deutschbein T ; Reimondo G ; Di Dalmazi G...
info:eu-repo/semantics/altIdentifier/pmid/35533704.  , 2022
Link: https://hdl.handle.net/1..
 
?
10

A multicenter epidemiological study on second malignancy in..:

Canu L ; Puglisi S ; Berchialla P...
info:eu-repo/semantics/altIdentifier/pmid/34830985.  , 2021
Link: http://hdl.handle.net/11..
 
?
11

Frequency and outcome of SARS-CoV-2 infection in patients w..:

Cosentini D ; Grisanti S ; Lagana M...
info:eu-repo/semantics/altIdentifier/pmid/33400171.  , 2021
Link: http://hdl.handle.net/23..
 
?
12

S-GRAS score for prognostic classification of adrenocortica..:

Elhassan, Y S ; Altieri, B ; Berhane, S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679848/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
13

What Is the Optimal Duration of Adjuvant Mitotane Therapy i..:

Basile, V ; Puglisi, S ; Altieri, B...
Basile , V , Puglisi , S , Altieri , B , Canu , L , Libe , R , Ceccato , F , Beuschlein , F , Quinkler , M , Calabrese , A , Perotti , P , Berchialla , P , Dischinger , U , Megerle , F , Baudin , E , Bourdeau , I , Lacroix , A , Loli , P , Berruti , A , Kastelan , D , Haak , H R , Fassnacht , M & Terzolo , M 2021 , ' What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question ' , Journal of Personalized Medicine , vol. 11 , no. 4 , 269 . https://doi.org/10.3390/jpm11040269.  , 2021
Link: https://cris.maastrichtu..
 
?
14

A multicenter epidemiological study on second malignancy in..:

Canu L ; Puglisi S ; Berchialla P...
volume:13.  , 2021
Link: http://hdl.handle.net/23..
 
?
15

What factors have impact on glucocorticoid replacement in a..:

Puglisi S ; Rossini A ; Tabaro I...
info:eu-repo/semantics/altIdentifier/pmid/32779106.  , 2021
Link: https://hdl.handle.net/1..
 
1-15